DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Braselmann S, Taylor V, Zhao H. et al.
R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation.
J Pharmacol Exp Ther 2006;
319 (03) 998-1008
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.